BlackRock Mid-Cap Growth Equity K (BMGKX)

Nasdaq • Currently up 0.59 (+1.78%) in today's trading session

1 member of Congress has disclosed 1 trade in BlackRock Mid-Cap Growth Equity K (BMGKX) via STOCK Act filings. The most recent disclosure was a sale by Blake Moore on 22 February 2021. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).

BlackRock Mid-Cap Growth Equity K is currently trading at $33.71, positioned at 15% of its 52-week range ($31.66 – $45.34).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$33.71
24h Change
+0.59 (+1.78%)
52 Week Range
$31.66–$45.34
View on NASDAQ

BlackRock Mid-Cap Growth Equity K Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for BMGKX

Select to highlight on chart
1 transactions
Compliance: 0%
Blake Moore22 Feb 202113 Aug 2022SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$5.69B

Volume

0

Beta

1.30

P/E Ratio

34.06

Fundamentals

EPS

$0.99

Div. Yield

33.28%

Open

$33.12

Day Range

$33.12 – $33.71

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
2016-03-28
Website
www.blackrock.com/us/individual/products/281439/blackrock-mid-cap-growth-equity-class-k-fund

This fund allocates a minimum of 80% of its net assets to stocks issued by U.S. companies with medium market capitalizations. The investment team seeks out businesses that they believe offer considerable potential for stronger-than-average earnings e...

No earnings data available for this stock.

Dividends

Dividend History

22 Jul 2026
Amount $5.2681
9 Dec 2025
Amount $5.9493
17 Jul 2025
Amount $1.7161
7 Dec 2021
Amount $0.7063
15 Jul 2021
Amount $1.6882
5 Dec 2019
Amount $0.1161
30 Apr 2019
Amount $0.0020
29 Mar 2019
Amount $0.0020
28 Feb 2019
Amount $0.0020
6 Dec 2018
Amount $1.0598
4 Dec 2017
Amount $0.7598

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about BMGKX

Which members of Congress have traded BMGKX?
1 member of Congress has disclosed 1 trade in BlackRock Mid-Cap Growth Equity K (BMGKX) under the STOCK Act: Blake Moore.
When was BMGKX most recently disclosed by Congress?
The most recent BMGKX disclosure was a sale by Blake Moore on 22 February 2021.
What is the total disclosed congressional trading volume for BMGKX?
Members of Congress have disclosed approximately $8K in BMGKX sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in BMGKX?
This BMGKX page updates as soon as new STOCK Act disclosures are filed for BlackRock Mid-Cap Growth Equity K. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.